NT$ 62
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
U-Neuron Biomedical Inc. specializes in the pioneering development of stem cell technologies. The company's core activities revolve around advancing methods for stem cell preservation, isolation, and their subsequent application in therapeutic treatments. Their research specifically targets Amniotic Fluid Stem Cells, Olfactory Stem Cells, and Adipose-derived Stem Cells. This enterprise was established on September 4, 2015, and is based in New Taipei, Taiwan.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Data is available to registered users only